Top Tech Companies (2,068)
Don't see your company?
Create a company profile
Epicrop develops a revolutionary epigenetic technology for improving crop yields.
ChemDiv offers flexible business models that helps you to manage development risk.
Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary manufacturing technology platform that produces allogeneic progenitor cell products with intellectual property protection under a low-oxygen, low-tension environment in a cGMP-compliant manufacturing facility. The company's lead drug candidate, ischemia-tolerant mesenchymal stem cells, or itMSCs, is an allogeneic progenitor cell therapy currently in clinical development for the treatment of ischemic stroke and Alzheimer’s disease. The company’s second drug candidate, ischemia-tolerant neural progenitor cells, or itNSCs, is an allogeneic cell therapy currently in development for spinal cord injury. In addition, Stemedica is developing progenitor multi-cell therapy (itMSCs and itNSCs) for ischemic stroke and progenitor cell and protein combination therapy for Alzheimer’s disease. More information on Stemedica may be found at www.stemedica.com.
For people who believe eating healthier should be effortless and tasty, The Not Company is a Foodtech, that reinvents animal-based foods using only plants. Unlike traditional food businesses, our company uses technology to recreate the same products we love to eat in a natural, sustainable and affordable way, keeping it functional, easy to use and mouthwateringly delicious.
BioBlocks is a medicinal research organization that provides medicinal chemistry services and products to pharmaceutical customers.
AbSci is a leading synthetic biology company that translates ideas into drugs with a platform technology that reinvents the biopharmaceutical drug discovery process.
Precise liquid handling for biology
OrganaBio is a Miami-based CDMO that manufactures clinical (cGMP) grade cells for cancer immunotherapy and regenerative medicine drug developers. OrganaBio’s vision is to accelerate the development of these drugs by giving developers access to (i) fresh and scalable tissue supplies; (ii) cell isolation, purification, expansion, and characterization services; (iii) process development services; and (iv) clinical-grade manufacturing services. At OrganaBio, we empower our customers’ people, process, and products on their journey to commercialization. Our team is comprised of highly motivated individuals who thrive in a fast-paced environment and are adept (and like) to deal with different tasks within a workweek.
Rubitection Inc is a medical device start-up focused on modernizing patient care and bringing awareness to the condition of pressure ulcers.
Serving the scientific community since 1925, Labconco Corporation manufactures laboratory equipment, specializing in ventilation products such as chemical fume hoods and blowers, ductless fume enclosures, balance enclosures, HEPA-filtered biological safety cabinets (BSCs), clean benches, glove boxes, and laboratory animal research enclosures. Other product lines include glassware washers, forensic enclosures, centrifugal concentrators, lyophilizers, evaporators, and water purification systems. Custom designed products are also available. Protecting your laboratory environment is the foundation of Labconco's product development efforts, and every Labconco product is designed with safety in mind. Its products' performance meets or exceeds industry standards including ANSI/ASHRAE 110-1995, NSF Standard 49 and UL 61010-1. Labconco employs more than 200 associates, every one taking pride in providing outstanding customer service. Labconco is ISO 9001:2008 certified, one measure of its commitment to quality and consistency in design and manufacturing. Through a worldwide network of distributors, Labconco serves a variety of laboratory customers around the globe, including universities, research centers, hospitals and government agencies.
BioGX is a proprietary platform-agnostic reagent technology.
Tenet Healthcare Corporation is one of the largest investor-owned health care delivery systems in the nation.
Normunity, Inc., is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. Normunity is located in Boston, Mass. and West Haven, Conn
The Eye Scan App is a product of sight4all, a digital health company that develops innovations in eye care technologies.
Invivyd is a biopharmaceutical company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Invivyd’s technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify high-quality, long-lasting antibodies with the potential to resist viral escape. The company is generating a robust pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications. Visit https://invivyd.com/ to learn more.
Maravai LifeSciences enables the miracles of science and improves the human condition through its portfolio of market-leading companies and proprietary technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid production and biologics safety testing. From inventive startups to many of the world's leading biopharma, vaccine, diagnostics and cell and gene therapy companies, customers turn to Maravai to solve their complex discovery challenges and help them streamline and scale from research through clinical trials. TriLink BioTechnologies is a global leader in RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades. Glen Research leads in specialty reagents for DNA and RNA oligonucleotide synthesis for a broad range of applications. Cygnus Technologies developed the market for bioprocess impurity detection, process-related impurity analytics and viral clearance prior to human trials, regulatory approval and commercial release. Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™. Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications. Founded in 2014 and headquartered in San Diego, Maravai LifeSciences is online at www.maravai.com.
We aim to advance urologic patient care through bold innovation, based on diversity of thought, openness to new ideas, adaptation to change, integrity and compassion. We develop innovative therapies and participate in exceptional licensing opportunities. Our goal is to be the leading specialty company: recognized and trusted by patients and providers for our commitment to urology. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated. Read more about our community guidelines: https://urovant.com/community-guidelines/
Neofluidics offers enhanced microfluidic tools that simplify workflow and reduce the cost of high throughput testing, culture, and analysis.
Access Genetics and OralDNA Labs are in the business of personalized diagnostics
Sepax Technologies, Inc., is Delaware based leading chromatography product manufacturer and service provider specializing in biological separation areas. We offer unique ranges of HPLC columns for bioanalytical characterization and testing, as well as process media for downstream process and purification of MAb, BsAb, ADC, Proteins, AAV, VLP, DNA, RNA, and various biologic samples. Sepax has a full portfolio of beads technology platforms, linker and organic synthesis chemistry, as well protein chemistry in different stages of R&D and production pipelines to support the various needs of biopharmaceutical industry and customers. Check out our website for more information www.sepax-tech.com
